Palonosetron Hydrochloride Injection
Product Images NDC 69097-927

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 69097-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

04460041 Adec 463b Ba9d 6a12038ab672 01

Chemical structure of palonosetron hydrochloride, depicting its molecular framework including multiple rings with nitrogen and oxygen atoms, and the hydrochloride moiety indicated as .HCl.*

FDA Label Image

04460041 Adec 463b Ba9d 6a12038ab672 02

Packaging label for Palonosetron hydrochloride Injection 0.25 mg/5 mL (0.05 mg/mL) by Cipla USA Inc. The label specifies a 5 mL single-use sterile vial for intravenous injection, includes storage instructions, and notes the product is Rx only. Manufacturer and distributor information is provided along with multiple barcodes and product codes.*

FDA Label Image

04460041 Adec 463b Ba9d 6a12038ab672 03

Palonosetron hydrochloride injection 0.25 mg/5 mL (0.05 mg/mL) single-use sterile vial label. The label indicates intravenous use only, storage temperature 20-25°C, and protection from light. Distributed by Cipla USA Inc., Sunrise, FL. The label includes NDC 69097-927-35 and barcode.*

FDA Label Image

0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 258 2

A vertical bar graph depicting differences in complete response rates, with data points showing percentages and ranges on an x-axis spanning from -10 to 35. The figure illustrates comparative response rates, likely for clinical efficacy, with error bars indicating confidence intervals or variability.*

FDA Label Image

0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 291 2

A chart displaying difference in complete response rates, with two data points marked approximately at 8% and 3% differences, corresponding to intervals shown by horizontal error bars (8%, 30%) and (3%, 27%). The x-axis represents the difference in complete response rates on a scale from -10 to 35.*

FDA Label Image

0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 293 2

A bar chart illustrating differences in Complete Response Rates, with vertical markers indicating percentages approximately from 0% to 31%. The x-axis shows the difference in response rates, spanning from -10.5 to 35. The chart is related to palonosetron hydrochloride injection but contains no further contextual details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.